Table 1

Demographic and Clinical Characteristics of Participants by Quartile of CAC Volume Score

Volume Score, QuartileAll Participants (N = 3,398)
1 (n = 852)2 (n = 847)3 (n = 850)4 (n = 849)
Volume range, mm32.34–24.5424.55–85.1985.20–273.39273.40–4,991.942.34–4,991.94
Age, yrs62.45 ± 9.8165.30 ± 9.3267.44 ± 9.1070.22 ± 8.1066.35 ± 9.53
Male420 (49.30)454 (53.60)511 (60.12)579 (68.20)1,964 (57.80)
Race/ethnicity
 Non-Hispanic white340 (39.91)320 (37.78)391 (46.00)446 (52.53)1,497 (44.06)
 African American224 (26.29)221 (26.09)187 (22.00)189 (22.26)821 (24.16)
 Hispanic183 (21.48)182 (21.49)165 (19.41)146 (17.20)676 (19.89)
 Chinese American105 (12.32)124 (14.64)107 (12.59)68 (8.01)404 (11.89)
Smoking status120 (14.13)105 (12.43)105 (12.35)106 (12.51)436 (12.86)
Systolic blood pressure, mm Hg126.46 ± 20.59130.55 ± 21.70131.73 ± 21.61134.51 ± 21.96130.81 ± 21.65
Blood pressure treatment308 (36.19)363 (42.86)409 (48.12)472 (55.59)1,552 (45.69)
Diabetes mellitus113 (13.75)129 (15.25)158 (18.65)203 (24.05)607 (17.92)
Total cholesterol, mg/dl196.95 ± 35.21193.47 ± 36.94194.81 ± 35.62193.23 ± 37.96194.62 ± 36.46
HDL-C, mg/dl49.81 ± 13.9049.73 ± 14.7449.19 ± 14.7748.92 ± 14.5349.41 ± 14.49
eGFR81.12 ± 17.5378.81 ± 18.4278.83 ± 24.1977.08 ± 18.4678.96 ± 19.87
Statin use138 (16.22)159 (18.77)176 (20.71)208 (24.50)681 (20.05)
ASCVD score0.13 ± 0.120.16 ± 0.130.20 ± 0.150.25 ± 0.150.19 ± 0.14
Density score2.05 ± 0.742.70 ± 0.622.91 ± 0.473.11 ± 0.382.69 ± 0.69
Agatston score9.55 ± 7.0548.80 ± 21.47170.92 ± 64.28942.97 ± 802.04292.92 ± 553.24
Agatston score13313–11251–353219–6,3161–6,316
Hard CHD34 (3.99)46 (5.44)82 (9.66)102 (12.04)264 (7.78)
Hard CVD54 (6.34)69 (8.16)121 (14.25)146 (17.24)390 (11.49)

Values are range, mean ± SD, or n (%).

ASCVD = atherosclerotic cardiovascular disease; CAC = coronary artery calcium; CHD = coronary heart disease; CVD = cardiovascular disease; eGFR = estimated glomerular filtration rate; HDL-C = high density lipoprotein cholesterol.